Pular para o conteúdo principal
Ranking Invest

ITGR - Integer Holdings Corporation

Segmento: HealthcareInteger Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Análise Ranking Invest

Valuation estimado
$ 1.95 Bi
Valor de Mercado
$ 4.28 Bi
Sobrepreço (AV)+119.2%
IVR
0.46A companhia vale 0,46 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.08O valuation alternativo equivale a 8% do valor de mercado da companhia.
MLL
0.08O lucro líquido dos controladores em 16 trimestres equivale a 8% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.72 Bi

Dívida Líquida

$ 1.22 Bi

L4T

$ 128.40 Mi

MM4T

6.91%

Indicadores Básicos

ROE

7.47%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

B0.22

Margem

B0.21

Índices de Tendência

Receita Líquida

A10.90

Lucro

B6.90

Margem

B5.18

Índices de Endividamento

DIV/PAT

0.71

DIV/L4T

9.47

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.